Michael Rogers
Direktor/Vorstandsmitglied bei AKEBIA THERAPEUTICS, INC.
Vermögen: 87 819 $ am 30.04.2024
Profil
Michael W.
Rogers is an Independent Director at Akebia Therapeutics, Inc. He previously served as the Chairman at Keryx Biopharmaceuticals, Inc. and as an Independent Director at Fortress Biotech, Inc., Aravive, Inc., EyePoint Pharmaceuticals, Inc., and Indevus Pharmaceuticals, Inc. He also held positions as Vice President-Investment Banking at Lehman Brothers, Inc. and PaineWebber, Inc. Additionally, he served as the Chief Financial Officer, Treasurer & Executive VP at Indevus Pharmaceuticals, Inc., AutoImmune, Inc., AHT Corp., Acorda Therapeutics, Inc., and BG Medicine, Inc. He obtained his undergraduate degree from Union College (New York) and an MBA from the University of Virginia Darden School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2024 | 66 029 ( 0,03% ) | 87 819 $ | 30.04.2024 | |
ARAVIVE, INC.
-.--% | 03.08.2023 | 0 ( -.--% ) | - $ | 31.12.2023 |
Aktive Positionen von Michael Rogers
| Unternehmen | Position | Beginn |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 12.12.2018 |
Ehemalige bekannte Positionen von Michael Rogers
| Unternehmen | Position | Ende |
|---|---|---|
| ARAVIVE, INC. | Direktor/Vorstandsmitglied | 17.01.2024 |
| AERPIO PHARMACEUTICALS | Finanzdirektor/CFO | 15.10.2019 |
| EYEPOINT PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.06.2019 |
| KERYX BIOPHARMACEUTICALS | Vorsitzender | 12.12.2018 |
| ACORDA THERAPEUTICS, INC. | Finanzdirektor/CFO | 04.10.2016 |
Ausbildung von Michael Rogers
| Union College (New York) | Undergraduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| BG MEDICINE, INC. | Health Technology |
| FORTRESS BIOTECH, INC. | Health Technology |
| ACORDA THERAPEUTICS, INC. | Health Technology |
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
AutoImmune, Inc.
 AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology AutoImmune, Inc. develop products to treat autoimmune and other cell-mediated inflammatory conditions. Its products are based on a biological mechanism known as oral tolerance, which provides tissue specific immunosuppression without toxicity or significant side effects. The company was founded in September 1988 and is headquartered in Pasadena, CA. | Health Technology |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
AHT Corp.
 AHT Corp. Services to the Health IndustryHealth Services AHT Corp. is a national provider of Internet-based clinical e-commerce among physicians, other healthcare provides and healthcare organizations. The company is focused on automating laboratory and prescription transactions. Its products principally focus on laboratory and prescription connectivity and transaction processing, including within the laboratory suite of applications, Dr. Chart (R), Dr. Chart Web (TM), Compliance Monitor (TM), CDR (TM) and CDM (TM) and its electronic prescription writing product.. The company was founded by Edelson Jonathan on June 20, 1995 and is headquartered in Tarrytown, NY. | Health Services |
| PaineWebber, Inc. | Finance |
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The firm's product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company was founded by Joseph H. Garder on November 16, 2007 and is headquartered in Cincinnati, OH. | Health Technology |
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA. | Health Technology |
